Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Narlaprevir/Ritonavir + Sofosbuvir in HCV GT1
NCT04246723Phase 2Completed
- Sponsor
- R-Pharm
- Start
- May 2019
- Primary completion
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of narlaprevir in chronic hepatitis C (CHC), sponsored by R-Pharm. Started May 2019; status: completed.
02
Drugs
narlaprevir
03
Conditions
chronic hepatitis C (CHC)
Beyond the preview
Go deeper on NCT04246723.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04246723.